Sign in

Publication

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Journal Paper/Review - Dec 3, 2007

Steinbild S, Burkholder I, Edler L, Hanauske A-R, Hochhaus A, Strumberg D, Dittrich C, Gillessen Sommer Silke, Morant R, Frost A, Mross K, Scheulen M

Steinbild, S
1
0
Mross, K
3
0
Frost, A
1
0
Morant, R
18
0
Gillessen Sommer, Silke
180
19
Dittrich, C
3
0
Strumberg, D
2
0
Hochhaus, A
2
0
Hanauske, A-R
1
0
Edler, L
1
0
Burkholder, I
1
0
Scheulen, M
1
0

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy